Want more wrestling news, rumors, and results? Be sure to visit PWInsider.com and PWInsiderXtra.com.
As the cannabis industry continues to expand, the opportunities for investors to capitalize on this burgeoning market have grown. With increased legalization, shifting public opinion, and an ever-diversifying range of products, marijuana companies are becoming more attractive to investors. 2024 is expected to be another strong year for the cannabis industry, especially with the ongoing development of innovative products like CBD gummies and oils, which have captured the interest of health-conscious consumers.
In this article, we’ll explore some of the best marijuana stocks to buy in 2024, providing insights into companies that are well-positioned for growth. We’ll also discuss how CBD gummies are playing a key role in the evolution of the cannabis market.
The marijuana industry is a dynamic sector that includes everything from cultivation to retail. As more states in the U.S. legalize marijuana for medical and recreational purposes, and as countries like Canada continue to see stable growth in their legal cannabis markets, the global marijuana market is projected to reach $100 billion by 2030. This market growth is driven by increasing demand for cannabis-based products, such as oils, topicals, and edibles.
Cannabis-based wellness products, particularly those containing CBD (cannabidiol), are contributing significantly to market expansion. Consumers are showing a growing interest in products that offer therapeutic benefits without the psychoactive effects of THC. CBD gummies, for instance, have become a popular option among consumers seeking relief from anxiety, inflammation, and sleep disorders, further driving demand for cannabis companies producing these goods.
With the industry booming, certain companies stand out due to their solid business models, strong market presence, and innovative product offerings. Here are the best marijuana stocks to buy in 2024:
Tilray Brands is a leading cannabis company that has gained prominence through its broad portfolio of cannabis products, including medical cannabis, recreational cannabis, and hemp-based wellness items. Tilray's focus on international markets, particularly in Europe, makes it a strong contender for long-term growth. Additionally, its merger with Aphria has allowed the company to further expand its market share in North America.
What makes Tilray particularly appealing in 2024 is its emphasis on product diversification. The company has entered the CBD market with a range of products, including CBD gummies. These gummies have become popular among consumers looking for natural remedies for stress, pain relief, and better sleep. Tilray’s ability to cater to this growing market positions it well for investors looking to benefit from the increasing demand for cannabis-based wellness products.
Canopy Growth Corporation is one of the largest cannabis companies in the world, with a presence in Canada, the U.S., and other international markets. Although the company has faced some financial struggles in recent years, its strategic moves and partnerships have kept it relevant and well-positioned for future growth.
One area where Canopy Growth has excelled is in its development of CBD-based products. The company has launched several lines of CBD gummies, which have become popular among wellness consumers for their potential health benefits. Canopy Growth’s focus on product innovation and partnerships with leading brands has allowed it to remain a key player in the cannabis industry. With plans to expand into the U.S. market further, Canopy Growth is a stock to watch in 2024.
Curaleaf Holdings is one of the most well-established cannabis companies in the U.S. market, operating in 23 states with over 140 retail locations. The company’s vertically integrated business model, which includes cultivation, processing, and retail, gives it a competitive edge.
Curaleaf has focused on expanding its product line, with a significant emphasis on wellness products such as CBD oils and gummies. The company’s CBD gummies are marketed as natural solutions for anxiety, stress, and general wellness, and they have quickly gained popularity among consumers. With the growing demand for these products and Curaleaf’s established presence in the U.S. market, the company is well-positioned to capitalize on the increasing consumer interest in CBD.
In 2024, Curaleaf is expected to continue its growth trajectory by expanding its product offerings and increasing its footprint in key markets. Investors looking for a cannabis company with a strong presence in both the medical and recreational markets should consider Curaleaf.
Green Thumb Industries (GTI) has earned a reputation as one of the most profitable and reliable cannabis companies in the U.S. The company operates over 80 retail locations under various brand names, with a focus on both medical and recreational cannabis.
GTI’s commitment to product diversity is one of its strengths. The company offers a wide range of products, including CBD gummies, which have seen increasing demand due to their potential health benefits. GTI’s CBD gummies are known for their quality, and the company’s strong focus on research and development has helped it maintain its leadership position in the market.
Green Thumb Industries has consistently reported positive cash flow and profitability, which sets it apart from many competitors in the cannabis space. With plans for continued expansion, GTI is a strong stock pick for investors looking for stability and growth in 2024.
Trulieve Cannabis is a dominant player in the U.S. medical marijuana market, particularly in Florida, where it operates over 180 dispensaries. Trulieve has been steadily expanding into other states, including Massachusetts and Pennsylvania, to increase its market share.
Trulieve has successfully tapped into the wellness market by offering a range of cannabis-based products, including CBD gummies. These gummies are designed to provide natural relief for a variety of ailments, such as anxiety and sleep issues, making them a popular choice among consumers seeking therapeutic benefits without the high associated with THC.
In 2024, Trulieve is expected to continue its aggressive expansion while maintaining its focus on the medical cannabis space. Its diverse product offerings, including the growing popularity of CBD products, make Trulieve an attractive option for investors looking for a strong cannabis stock.
CBD (cannabidiol) has emerged as one of the most important components of the cannabis industry, particularly in the wellness sector. Unlike THC, CBD does not produce psychoactive effects, making it an appealing option for consumers who want the therapeutic benefits of cannabis without feeling "high."
One of the most popular forms of CBD consumption is through gummies. CBD gummies have gained significant traction in recent years due to their ease of use, discreet nature, and potential health benefits. Consumers are turning to CBD gummies for a variety of reasons, including:
Stress and Anxiety Relief: Many users report that CBD helps them manage stress and anxiety, making CBD gummies a popular choice for those seeking a natural remedy.
Pain Management: CBD has anti-inflammatory properties that may help alleviate chronic pain. Gummies offer a convenient way to consume CBD for this purpose.
Improved Sleep: Some consumers use CBD gummies to improve sleep quality, as CBD is believed to have a calming effect that promotes relaxation.
As demand for natural wellness products grows, the market for CBD gummies is expected to expand further. Cannabis companies that offer high-quality CBD products are likely to benefit from this trend, as more consumers seek out alternatives to traditional pharmaceuticals for managing their health.
The cannabis industry is poised for significant growth in 2024, and investors have several opportunities to capitalize on this trend. Companies like Tilray, Canopy Growth, Curaleaf, Green Thumb Industries, and Trulieve are well-positioned to lead the market, thanks to their innovative product offerings and strong market presence.
CBD gummies are playing a crucial role in the evolution of the cannabis industry, particularly within the wellness sector. As consumer interest in CBD continues to rise, companies that offer high-quality CBD products, including gummies, are expected to thrive in the coming years. For investors looking to gain exposure to the growing cannabis market, these stocks represent some of the best opportunities in 2024.
If you enjoy PWInsider.com you can check out the AD-FREE PWInsider Elite section, which features exclusive audio updates, news, our critically acclaimed podcasts, interviews and more by clicking here!
Bang On Casino
